Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
29.05
+0.56 (1.97%)
Jun 9, 2026, 4:00 PM EDT - Market closed

Roivant Sciences Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
20,89519,9547,0228,5025,6103,433
Market Cap Growth
169.39%184.16%-17.41%51.56%63.40%-46.12%
Enterprise Value
16,71016,5232,7252,5324,8122,050
Last Close Price
29.0527.7010.0910.547.384.94
PE Ratio
---2.02--
PS Ratio
2529.642415.71241.70259.9191.5462.10
PB Ratio
4.624.411.501.424.852.07
P/TBV Ratio
4.454.251.561.474.542.00
EV/Sales Ratio
2023.052000.3993.8077.4178.5237.08
EV/EBITDA Ratio
---0.56--
EV/EBIT Ratio
---0.56--
Debt / Equity Ratio
0.020.020.020.010.270.13
Debt / EBITDA Ratio
---0.01--
Net Debt / Equity Ratio
-0.92-0.92-1.02-1.08-1.03-1.07
Net Debt / EBITDA Ratio
8.188.184.84-1.421.031.32
Net Debt / FCF Ratio
5.525.525.678.401.402.56
Asset Turnover
0.000.000.000.010.020.02
Quick Ratio
18.0018.0032.7124.356.1511.18
Current Ratio
18.3718.3733.4725.246.6011.64
Return on Equity (ROE)
-7.75%-7.59%-12.54%112.87%-67.05%-44.82%
Return on Assets (ROA)
-14.17%-13.90%-16.97%93.13%-47.45%-52.26%
Return on Invested Capital (ROIC)
-89.37%-97.12%-200.44%698.00%-210.89%-274.55%
Return on Capital Employed (ROCE)
-9.81%-9.61%-16.39%99.13%-52.03%-56.65%
Earnings Yield
---49.62%--
Buyback Yield / Dilution
4.35%4.35%12.71%-16.59%-6.43%-6.30%
Total Shareholder Return
4.35%4.35%12.71%-16.59%-6.43%-6.30%
SEC Filings: 10-K · 10-Q